Inhibitors of protein farnesylation

Expert Opinion on Therapeutic Patents

Volumn 6, Issue 12, 1996, Pages 1295-1304

  Graham, S L ^a   Williams, T M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 [[2 [(2 AMINO 3 MERCAPTOPROPYL)AMINO] 3 METHYLPENTYL]OXY] 1 OXO 3 PHENYLPROPYL]AMINO] 4 (METHYLSULFONYL)BUTANOIC ACID ISOPROPYL ESTER; ANDRASTIN C; ANTINEOPLASTIC AGENT; AQUAYAMYCIN; BENZODIAZEPINE DERIVATIVE; BIPHENYL DERIVATIVE; BZA 56; GQTI 287; N (8 AMINO 2 BENZYL 5 ISOPROPYL 9 MERCAPTO 3,6 NONADIENOYL)METHIONINE; N [2 [2 (2 AMINO 3 MERCAPTOPROPYLAMINO) 3 METHYLPENTYLOXY] 3 PHENYLPROPIONYL]METHIONINE SULFONE METHYL ESTER; N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE; PD 331; PROTEIN FARNESYLTRANSFERASE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; SAQUAYAMYCIN A; SCH 58540; TAN 1831; TETRAHYDROISOQUINOLINE DERIVATIVE; TETRALIN DERIVATIVE; UNCLASSIFIED DRUG; VALINOCTIN A;

CANCER; CANCER INHIBITION; DRUG MECHANISM; ENZYME KINETICS; HUMAN; NONHUMAN; PATENT; PROTEIN MODIFICATION; REVIEW; SCIENTIFIC LITERATURE;

EID: 0030447822     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.6.12.1295     Document Type: Review

References (0)